BEGIN:VCALENDAR
VERSION:2.0
PRODID:-// - ECPv6.6.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.biomed.cas.cz
X-WR-CALDESC:Akce na 
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Prague
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Prague:20251217T150000
DTEND;TZID=Europe/Prague:20251217T160000
DTSTAMP:20260419T055201
CREATED:20251202T073428Z
LAST-MODIFIED:20251202T073428Z
UID:2467-1765983600-1765987200@www.biomed.cas.cz
SUMMARY:Seminář  Mehak Nihal Shaikh
DESCRIPTION:“ALDH1A1 inhibition as a therapeutic target in Acute Myeloid Leukemia” \nAcute Myeloid Leukemia (AML) is a hematological malignancy leading to differentiation arrest of the myeloid compartment in the bone marrow. It is reported that high levels of ALDH1A1 inhibition promote chemoresistance in AML. Therefore\, in my project we are studying the role of ALDH1A1 inhibition in AML using AML cell lines\, mouse models\, and AML patient samples. And lastly\, we will show the effect of ALDH1A1 inhibition in combination with standard of care chemotherapeutic drugs as a potential treatment strategy for AML. \n 
URL:https://www.biomed.cas.cz/event/seminar-mehak-nihal-shaikh/
LOCATION:Posluchárna Milana Haška / Milan Hašek Auditorium
ORGANIZER;CN="%C3%9AMG":MAILTO:leona.krausova@img.cas.cz
END:VEVENT
END:VCALENDAR